Sees FY24 R&D expenses EUR 2.4B-EUR 2.6B; SG&A expenses EUR 700M-EUR 800M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTX:
- BNTX Upcoming Earnings Report: What to Expect?
- BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
- BioNTech SE Virtual AGM Scheduled for May 2024
- BioNTech Reports Promising Cancer Vaccine Data
- BioNTech announces Phase 1 trial follow up data for mRNA-based iNeST candidate
